Supporting multidisciplinary staff meetings for guideline-based breast cancer management: a study with OncoDoc2

Por Séroussi, B., Bouaud, J., Gligorov, J., Uzan, S.
Publicado em 2007

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

Por Séroussi, B, Laouénan, C, Gligorov, J, Uzan, S, Mentré, F, Bouaud, J
Publicado em 2013

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

Por Selle, F., Gligorov, J., Richard, S., Khalil, A., Alexandre, I., Avenin, D., Provent, S., Soares, D.G., Lotz, J.P.
Publicado no Braz J Med Biol Res (2014)

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

Por Fajac, A, Gligorov, J, Rezai, K, Lévy, P, Lévy, E, Selle, F, Beerblock, K, Avenin, D, Saintigny, P, Hugonin, S, Bernaudin, J-F, Lokiec, F
Publicado em 2010

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

Por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado em 2014